Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-18

Clinical Trial Update: Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating estetrol's impact on testosterone suppression and quality of life in prostate cancer patients on an LHRH agonist has been comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estetrol (estetrol)

Snippet

Sponsor: Pantarhei Oncology B.V. | Conditions: Prostatic Neoplasm | Phase 2 | Status: COMPLETED